633
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluations

Trastuzumab emtansine in breast cancer

, MD PhD, , MD, , MD & , MD
Pages 607-614 | Published online: 11 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Claudia T Mendler, Lars Friedrich, Iina Laitinen, Martin Schlapschy, Markus Schwaiger, Hans-Jürgen Wester & Arne Skerra. (2015) High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation. mAbs 7:1, pages 96-109.
Read now

Articles from other publishers (5)

Catharina Bartmann, Joachim Diessner, Maria Blettner, Sebastian Häusler, Wolfgang Janni, Rolf Kreienberg, Mathias Krockenberger, Lukas Schwentner, Roland Stein, Tanja Stüber, Achim Wöckel & Manfred Wischnewsky. (2017) Factors influencing the development of visceral metastasis of breast cancer: A retrospective multi-center study. The Breast 31, pages 66-75.
Crossref
Michaela Gebauer & Arne Skerra. 2015. Biobetters. Biobetters 221 268 .
Michael H. R. Eichbaum & Christine Eichbaum. (2013) Trastuzumab: subkutan appliziert so wirksam wie die intraven?se Gabe. Info Onkologie 16:5, pages 26-27.
Crossref
Ruchi Malik, Anil Wagh, Steven Qian & Benedict Law. (2013) A single-layer peptide nanofiber for enhancing the cytotoxicity of trastuzumab (anti-HER). Journal of Nanoparticle Research 15:6.
Crossref
Masahiro Yasunaga, Shino Manabe & Yasuhiro Matsumura. (2013) Tumor stromal barrier and cancer stromal targeting therapy. Microvascular Reviews and Communications 6:1, pages 2-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.